WPI 2265 (Acitretin 22.5 mg)

Pill imprint WPI 2265 has been identified as Acitretin 22.5 mg.

Acitretin is used in the treatment of psoriasis; psoriatic arthritis; pityriasis rubra pilaris and belongs to the drug class antipsoriatics. Not for use in pregnancy. Acitretin 22.5 mg is not a controlled substance under the Controlled Substance Act (CSA).

Acitretin

Imprint:

WPI 2265

Strength:

22.5 mg

Color:

Brown

Shape:

Capsule-shape

Availability:

Prescription only

Drug Class:

Antipsoriatics

Pregnancy Category:

X - Not for use in pregnancy

CSA Schedule:

Not a controlled drug

Manufacturer:

Actavis Pharma, Inc.

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.